Pathogenic variants of PMM2 cause congenital disorder of glycosylation type Ia, also known as PMM2-CDG: a genetic disease characterized by encephalopathy, movement disorders, and cerebellar hyperplasia32. This evidence concerns the gene PMM2 and Encephalopathy.